Event-Driven Stocks

INTEGRATED BIOPHARMA INC

INBPOTC

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 6 good● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$54.4M$50.3M$50.7M$56.2M$63.6M$52.8M
Operating income$2.0M$251,000$120,000$2.7M$5.8M$3.3M
Net income$808,000$112,000−$34,000$3.8M$8.0M$4.1M
Total assets$24.9M$26.2M$25.4M$25.3M$25.4M$22.9M
Total liabilities$4.6M$7.0M$6.6M$6.7M$11.1M$16.9M
Equity$20.3M$19.2M$18.9M$18.6M$14.3M$6.1M
EPS (diluted)$0.03$0.00$0.00$0.12$0.25$0.13
Shares out.31.1M30.1M29.9M29.9M29.8M29.6M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
3.7%
Net margin
1.5%
Return on equity
4.0%
Return on assets
3.2%
Return on capital (ROCE)
9.8%
Liabilities / assets
18.4%
Debt / equity
0.23×
Book value / share
$0.65
Revenue growth (YoY)
8.0%
Net income growth (YoY)
621.4%

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
4.91safe
Accruals / assets
−5.0%clean
Beneish M-Score
-2.71normal
Piotroski F-Score
8/9strong

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
93
/ 100
Profitability 100Growth 100Catalyst 67Earnings quality 100Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 1 severe● 6 good
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating margin is positive
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Positive operating cash flow
  • Clean earnings (low accruals)
  • Altman Z″ in the safe zone

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 20262,1011.00.0%
Apr 30, 20262,1011.00.0%
Apr 15, 20262,1011.00.0%
Mar 31, 20262,1011.0-73.2%
Mar 13, 20267,8495.7+5.2%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)